e-learning
resources
Virtual 2020
Pre-Congress Content
Advances in asthma treatment
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Late Breaking Abstract - Pharmacological and clinical management of severe asthma in 9 countries: An international survey of clinicians.
O. Efthymiadou (London, United Kingdom), B. Kamphuis (London, United Kingdom), V. Tzouma (London, United Kingdom), P. Kanavos (London, United Kingdom)
Source:
Virtual Congress 2020 – Advances in asthma treatment
Session:
Advances in asthma treatment
Session type:
E-poster session
Number:
2611
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
O. Efthymiadou (London, United Kingdom), B. Kamphuis (London, United Kingdom), V. Tzouma (London, United Kingdom), P. Kanavos (London, United Kingdom). Late Breaking Abstract - Pharmacological and clinical management of severe asthma in 9 countries: An international survey of clinicians.. 2611
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Management of Severe Asthma in Pediatric Patients by an Interdisciplinary Team in a Public Hospital Setting.
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Related content which might interest you:
International perspectives on severe asthma: Current and future challenges in patient care
Source: International Congress 2016 – Asthma points to ponder
Year: 2016
Late Breaking Abstract - Second Souffle: preliminary results from a national survey on the care pathways and quality of life of patients with T2 severe asthma
Source: Virtual Congress 2021 – Airway pharmacology: translational and basic science
Year: 2021
Implementation of personalized treatment of asthma by improved phenotyping: Critical review of knowledge gaps and unmet research needs by the European asthma research & innovation partnership (EARIP) expert panel
Source: International Congress 2016 – Phenotyping asthma
Year: 2016
Late Breaking Abstract - Reimbursement for asthma care is a universal barrier to achieving asthma symptom control: the SABINA III study
Source: Virtual Congress 2020 – Personalised treatment of obstructive diseases
Year: 2020
Late Breaking Abstract - Idiopathic Pulmonary Fibrosis – a worldwide review of ‘real’ life’ practice: experience from a treatment feasibility review in 41 countries
Source: International Congress 2018 – ILDs: From bench to bedside
Year: 2018
The disease burden of mild asthma: Findings from a 2013 real world survey
Source: International Congress 2016 – Asthma and allergy in infancy: from risk factors to mortality
Year: 2016
Late Breaking Abstract - Real world patient-reported outcomes in asthma across six European countries: the NEWTON study
Source: Virtual Congress 2021 – Airway pharmacology: translational and basic science
Year: 2021
Late Breaking Abstract - The humanistic burden of asthma patients uncontrolled on ICS-LABA: a systematic literature review
Source: Virtual Congress 2020 – Inhaled corticosteroids and bronchodilator studies in asthma
Year: 2020
Late Breaking Abstract - Knowledge, anxiety and use of hydroxychloroquine prophylaxis among healthcare students and professionals regarding COVID-19 pandemic in India: An observational cross-sectional study
Source: Virtual Congress 2020 – COVID-19 clinical studies
Year: 2020
Severe T2-high asthma in the biologics era: European experts' opinion
Source: Eur Respir Rev, 28 (152) 190054; 10.1183/16000617.0054-2019
Year: 2019
Late Breaking Abstract - COPD patient´s adherence to pulmonary rehabilitation programs: scoping review
Source: Virtual Congress 2021 – Pulmonary rehabilitation in asthma and COPD
Year: 2021
Late Breaking Abstract - International, prospective real-world study of mepolizumab in patients with severe asthma at one year: REALITI-A
Source: Virtual Congress 2021 – Advances in asthma treatment
Year: 2021
Inappropriate asthma therapy: A tale of two countries
Source: International Congress 2016 – Asthma: treatment, disease control, and quality of life
Year: 2016
Late Breaking Abstract - Defining a severe asthma super-responder: findings from a Delphi process
Source: Virtual Congress 2020 – Advances in asthma treatment
Year: 2020
A national database study of the effectiveness of switching real-life asthma patients to fostair
Source: International Congress 2015 – New data on established treatments for asthma, COPD and bronchiectasis
Year: 2015
Prevalence of asthma and management of exacerbations in general practice (GP) after computerised Spanish guideline on the management of asthma (GEMA) and collaborative care environment
Source: International Congress 2015 – Management of asthma and COPD in primary care
Year: 2015
Late Breaking Abstract - Comparative analysis of effectiveness of Asthma Control Test-guided treatment versus usual care in patients with asthma from China
Source: Virtual Congress 2020 – Prediction of outcomes in obstructive diseases
Year: 2020
Treatment trends for asthma-COPD overlap syndrome patients: Findings from a real world survey
Source: International Congress 2016 – Burden of respiratory diseases: from environmental aspects to healthcare consumption
Year: 2016
Decision analytic models in COPD/asthma: A critical review of current evidence
Source: International Congress 2016 – How the increasing complexity of chronic care management challenges ethics and costs in our healthcare system
Year: 2016
Perception of asthma control by patients: results of a survey in 5 European countries
Source: Annual Congress 2007 - Towards controlling severe asthma
Year: 2007
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept